Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla

Table 3 Baseline characteristics of patients receiving aminophylline vs those not receiving Aminophylline

Characteristic	Aminophylline	No Aminophylline	P Value
	(n = 41)	(n = 67)
Age ± SD	63 ± 17	59 ± 17	0.24
Male sex (%)	22 (54)	28 (42)	0.31
Caucasian (%)	9 (22)	11 (16)	0.54
Diabetes (%)	8 (20)	26 (39)	0.06
Hypertension (%)	31 (76)	48 (72)	0.90
Hyperlipidemia (%)	26 (63)	32 (48)	0.17
Current smoker (%)	8 (20)	13 (19)	0.93
10 yr Framingham risk ± SD	24 ± 14	23 ± 20	0.75
Baseline heart rate	71 ± 12	69 ± 15	0.47
Baseline blood pressure:
Systolic	129 ± 19	124 ± 14	0.12
Diastolic	66 ± 15	68 ± 19	0.57
Peak heart rate	96 ± 17	93 ± 18	0.39
Peak blood pressure:
Systolic	126 ± 18	125 ± 15	0.76
Diastolic	63 ± 15	67 ± 18	0.24

BMI = body/mass index; CAD = coronary artery disease; SD = standard deviation. MPR was calculated as peak CS flow/pre CS flow.

ISSN: 1532-429X